Natural Health Trends financials
$1.03+4.04%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.6M | $9.2M | $9.7M | $9.5M | $9.8M | $10.7M | $10.8M | $10.7M | $10.5M | $11.0M | $10.9M | $10.6M |
| Gross profit | $5.7M | $6.9M | $7.1M | $7.0M | $7.3M | $7.9M | $8.0M | $7.9M | $7.8M | $8.0M | $8.1M | $7.9M |
| Gross margin | 75.2% | 75.0% | 72.9% | 73.7% | 73.9% | 73.6% | 74.2% | 74.1% | 74.2% | 73.4% | 74.5% | 74.7% |
| Operating income | -$643.0K | -$474.0K | -$635.0K | -$495.0K | -$333.0K | -$345.0K | -$421.0K | -$275.0K | -$238.0K | -$365.0K | -$242.0K | -$292.0K |
| Net income | -$451.0K | -$154.0K | -$588.0K | -$431.0K | $15.0K | $122.0K | $176.0K | $35.0K | $173.0K | $188.0K | $358.0K | $172.0K |
| Net margin | −5.9% | −1.7% | −6.0% | −4.5% | 0.2% | 1.1% | 1.6% | 0.3% | 1.7% | 1.7% | 3.3% | 1.6% |
| Diluted EPS | $-0.05 | $-0.02 | $-0.05 | $-0.04 | $0.00 | $0.01 | $0.02 | $0.00 | $0.02 | $0.02 | $0.03 | $0.02 |
| EBITDA | -$620.0K | -$463.0K | -$613.0K | -$467.0K | -$304.0K | -$315.0K | -$390.0K | -$244.0K | -$204.0K | -$330.0K | -$208.0K | -$253.0K |
| Operating cash flow | -$1.4M | -$797.0K | -$959.0K | $113.0K | -$5.6M | $484.0K | $88.0K | -$436.0K | -$3.6M | $549.0K | -$69.0K | -$869.0K |
| Free cash flow | -$1.7M | -$912.0K | -$964.0K | $70.0K | -$5.6M | $468.0K | $68.0K | -$443.0K | -$3.6M | $538.0K | -$83.0K | -$887.0K |
| Diluted shares | 8.6M | 10.1M | 11.5M | 11.5M | 11.5M | 11.5M | 11.5M | 11.5M | 11.5M | 11.5M | 11.5M | 11.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.5M | $9.2M | $6.8M | $14.3M | $10.5M | $21.7M |
| Short-term investments | $9.1M | $12.0M | $22.1M | $17.7M | $23.7M | $20.2M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $29.2M | $31.9M | $38.4M | $42.3M | $45.2M | $53.2M |
| Total liabilities | $14.0M | $15.5M | $15.0M | $16.1M | $16.3M | $22.3M |
| Shareholders' equity | $15.2M | $16.5M | $23.4M | $26.1M | $28.9M | $30.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology